Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioRestorative Therapies, Inc.
  6. News
  7. Summary
    BRTX   US0906556065

BIORESTORATIVE THERAPIES, INC.

(BRTX)
  Report
Delayed Nasdaq  -  05/18 03:59:51 pm EDT
3.750 USD   +2.74%
05/16BioRestorative Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/16BIORESTORATIVE THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
05/05Certain Common Stock of BioRestorative Therapies, Inc. are subject to a Lock-Up Agreement Ending on 5-MAY-2022.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

After Hours Watch List Scorecard: BRTX, AIR, CAMP

12/22/2021 | 05:16pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
AAR CORP. -2.08% 46.16 Delayed Quote.18.27%
BIORESTORATIVE THERAPIES, INC. 2.74% 3.75 Delayed Quote.-13.59%
CALAMP CORP. 3.69% 5.9 Delayed Quote.-19.41%
All news about BIORESTORATIVE THERAPIES, INC.
05/16BioRestorative Therapies, Inc. Reports Earnings Results for the First Quarter Ended Mar..
CI
05/16BIORESTORATIVE THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
05/05Certain Common Stock of BioRestorative Therapies, Inc. are subject to a Lock-Up Agreeme..
CI
04/29BioRestorative Therapies Hosts Principal Investigator Meeting for its BRTX-100® Phase 2..
GL
04/18BioRestorative Therapies Picks 10 US Clinical Sites for Trial of Spine Condition Treatm..
MT
04/18BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clini..
AQ
04/18BioRestorative Therapies, Inc. Announces Selection of 10 Clinical Sites for its Phase 2..
CI
04/07INSIDER BUY : BioRestorative Therapies
MT
04/04BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification
AQ
03/30BIORESTORATIVE THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
More news
Analyst Recommendations on BIORESTORATIVE THERAPIES, INC.
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -7,85 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,75x
Yield 2022 -
Capitalization 13,6 M 13,6 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 7
Free-Float 73,0%
Chart BIORESTORATIVE THERAPIES, INC.
Duration : Period :
BioRestorative Therapies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 3,75 $
Average target price 37,00 $
Spread / Average Target 887%
EPS Revisions
Managers and Directors
Lance Alstodt Chairman, President & Chief Executive Officer
Robert E. Kristal Chief Financial Officer
Francisco J. Silva Secretary, Director & VP-Research & Development
Robert Paccasassi Vice President-Quality & Compliance
Patrick F. Williams Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BIORESTORATIVE THERAPIES, INC.-13.59%13
GILEAD SCIENCES, INC.-12.93%79 248
REGENERON PHARMACEUTICALS, INC.4.38%71 927
VERTEX PHARMACEUTICALS14.91%66 967
WUXI APPTEC CO., LTD.-18.77%42 682
BIONTECH SE-38.01%38 834